Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZamCAT: Chlorhexidine Cord Cleansing
NCT01241318Phase 3Completed
- Sponsor
- Boston University
- Start
- Feb 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chlorhexidine in omphalitis and neonatal sepsis (2 arms), sponsored by Boston University. Primary endpoints: All-cause Neonatal Mortality and All-cause Neonatal Mortality Among Newborns Who Survived at Least First Day of Life. Started Feb 2011; status: completed.
02
Drugs
chlorhexidine
03
Conditions
omphalitisneonatal sepsis
Beyond the preview
Go deeper on NCT01241318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241318.